Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Daily Top 10 COVID-19 publications Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe

Vaccines

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 76 articles: HTML format

Single Articles

May 2020
1. WELLS CR, Huppert A, Fitzpatrick MC, Pandey A, et al
   Prosocial polio vaccination in Israel.
   Proc Natl Acad Sci U S A. 2020 May 26. pii: 1922746117.
   PubMed     Abstract available
   
   
   March 2020
2. PEEPLES L
   News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.
   Proc Natl Acad Sci U S A. 2020 Mar 30. pii: 2005456117.
   PubMed    
   
   
   
3. TIAN M, McGovern K, Cheng HL, Waddicor P, et al
   Conditional antibody expression to avoid central B cell deletion in humanized HIV-1 vaccine mouse models.
   Proc Natl Acad Sci U S A. 2020 Mar 24. pii: 1921996117.
   PubMed     Abstract available
   
   
   
4. SUTTER G
   A vital gene for modified vaccinia virus Ankara replication in human cells.
   Proc Natl Acad Sci U S A. 2020 Mar 16. pii: 2001335117.
   PubMed    
   
   
   
5. WEC AZ, Haslwanter D, Abdiche YN, Shehata L, et al
   Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine.
   Proc Natl Acad Sci U S A. 2020 Mar 9. pii: 1921388117.
   PubMed     Abstract available
   
   
   February 2020
6. HLADISH TJ, Pearson CAB, Toh KB, Rojas DP, et al
   Designing effective control of dengue with combined interventions.
   Proc Natl Acad Sci U S A. 2020;117:3319-3325.
   PubMed     Abstract available
   
   
   
7. PENG C, Moss B
   Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.
   Proc Natl Acad Sci U S A. 2020 Feb 4. pii: 1921098117.
   PubMed     Abstract available
   
   
   January 2020
8. LANGOWSKI MD, Khan FA, Bitzer AA, Genito CJ, et al
   Optimization of a Plasmodium falciparum circumsporozoite protein repeat vaccine using the tobacco mosaic virus platform.
   Proc Natl Acad Sci U S A. 2020 Jan 27. pii: 1911792117.
   PubMed     Abstract available
   
   
   
9. NEWMAN JH, Chesson CB, Herzog NL, Bommareddy PK, et al
   Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer.
   Proc Natl Acad Sci U S A. 2020;117:1119-1128.
   PubMed     Abstract available
   
   
   
10. OZDILEK A, Paschall AV, Dookwah M, Tiemeyer M, et al
    Host protein glycosylation in nucleic acid vaccines as a potential hurdle in vaccine design for nonviral pathogens.
    Proc Natl Acad Sci U S A. 2020 Jan 6. pii: 1916131117.
    PubMed     Abstract available
    
    
    December 2019
11. VIRK RK, Jayakumar J, Mendenhall IH, Moorthy M, et al
    Divergent evolutionary trajectories of influenza B viruses underlie their contemporaneous epidemic activity.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1916585116.
    PubMed     Abstract available
    
    
    
12. YU KM, Park SJ, Yu MA, Kim YI, et al
    Cross-genotype protection of live-attenuated vaccine candidate for severe fever with thrombocytopenia syndrome virus in a ferret model.
    Proc Natl Acad Sci U S A. 2019 Dec 9. pii: 1914704116.
    PubMed     Abstract available
    
    
    November 2019
13. PAES W, Leonov G, Partridge T, Chikata T, et al
    Contribution of proteasome-catalyzed peptide cis-splicing to viral targeting by CD8(+) T cells in HIV-1 infection.
    Proc Natl Acad Sci U S A. 2019 Nov 20. pii: 1911622116.
    PubMed     Abstract available
    
    
    October 2019
14. HOEHN KB, Vander Heiden JA, Zhou JQ, Lunter G, et al
    Repertoire-wide phylogenetic models of B cell molecular evolution reveal evolutionary signatures of aging and vaccination.
    Proc Natl Acad Sci U S A. 2019 Oct 21. pii: 1906020116.
    PubMed     Abstract available
    
    
    
15. 
    Correction for Sah et al., Future epidemiological and economic impacts of universal influenza vaccines.
    Proc Natl Acad Sci U S A. 2019 Oct 21. pii: 1917260116.
    PubMed    
    
    
    
16. IRENE C, Fantappie L, Caproni E, Zerbini F, et al
    Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine.
    Proc Natl Acad Sci U S A. 2019 Oct 7. pii: 1905112116.
    PubMed     Abstract available
    
    
    September 2019
17. SHAFFER L
    Inner Workings: Lyme disease vaccines face familiar challenges, both societal and scientific.
    Proc Natl Acad Sci U S A. 2019;116:19214-19217.
    PubMed    
    
    
    
18. SAH P, Alfaro-Murillo JA, Fitzpatrick MC, Neuzil KM, et al
    Future epidemiological and economic impacts of universal influenza vaccines.
    Proc Natl Acad Sci U S A. 2019 Sep 23. pii: 1909613116.
    PubMed     Abstract available
    
    
    
19. NOBIS CC, Dubeau Laramee G, Kervezee L, Maurice De Sousa D, et al
    The circadian clock of CD8 T cells modulates their early response to vaccination and the rhythmicity of related signaling pathways.
    Proc Natl Acad Sci U S A. 2019 Sep 16. pii: 1905080116.
    PubMed     Abstract available
    
    
    
20. RASHEED MAU, Hickman CJ, McGrew M, Sowers SB, et al
    Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood.
    Proc Natl Acad Sci U S A. 2019 Sep 3. pii: 1905570116.
    PubMed     Abstract available
    
    
    August 2019
21. FELDMAN MF, Mayer Bridwell AE, Scott NE, Vinogradov E, et al
    A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae.
    Proc Natl Acad Sci U S A. 2019 Aug 27. pii: 1907833116.
    PubMed     Abstract available
    
    
    
22. DE LIMA DS, Cardozo LE, Maracaja-Coutinho V, Suhrbier A, et al
    Long noncoding RNAs are involved in multiple immunological pathways in response to vaccination.
    Proc Natl Acad Sci U S A. 2019 Aug 9. pii: 1822046116.
    PubMed     Abstract available
    
    
    July 2019
23. BOOPATHY AV, Mandal A, Kulp DW, Menis S, et al
    Enhancing humoral immunity via sustained-release implantable microneedle patch vaccination.
    Proc Natl Acad Sci U S A. 2019 Jul 29. pii: 1902179116.
    PubMed     Abstract available
    
    
    
24. ANGELETTI D, Kosik I, Santos JJS, Yewdell WT, et al
    Outflanking immunodominance to target subdominant broadly neutralizing epitopes.
    Proc Natl Acad Sci U S A. 2019;116:13474-13479.
    PubMed     Abstract available
    
    
    June 2019
25. DEERE JD, Chang WLW, Villalobos A, Schmidt KA, et al
    Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.
    Proc Natl Acad Sci U S A. 2019 Jun 12. pii: 1903317116.
    PubMed     Abstract available
    
    
    May 2019
26. LU Y, Stuart JH, Talbot-Cooper C, Agrawal-Singh S, et al
    Histone deacetylase 4 promotes type I interferon signaling, restricts DNA viruses, and is degraded via vaccinia virus protein C6.
    Proc Natl Acad Sci U S A. 2019 May 24. pii: 1816399116.
    PubMed     Abstract available
    
    
    
27. WANG S, Qin L, Yamankurt G, Skakuj K, et al
    Rational vaccinology with spherical nucleic acids.
    Proc Natl Acad Sci U S A. 2019 May 8. pii: 1902805116.
    PubMed     Abstract available
    
    
    April 2019
28. WELLS CR, Pandey A, Parpia AS, Fitzpatrick MC, et al
    Ebola vaccination in the Democratic Republic of the Congo.
    Proc Natl Acad Sci U S A. 2019 Apr 29. pii: 1817329116.
    PubMed     Abstract available
    
    
    
29. WEIDENBACHER PA, Kim PS
    Protect, modify, deprotect (PMD): A strategy for creating vaccines to elicit antibodies targeting a specific epitope.
    Proc Natl Acad Sci U S A. 2019 Apr 26. pii: 1822062116.
    PubMed     Abstract available
    
    
    March 2019
30. STEFANETTI G, Okan N, Fink A, Gardner E, et al
    Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to Francisella tularensis.
    Proc Natl Acad Sci U S A. 2019 Mar 14. pii: 1900144116.
    PubMed     Abstract available
    
    
    
31. SHEN L, Frencher J, Huang D, Wang W, et al
    Immunization of Vgamma2Vdelta2 T cells programs sustained effector memory responses that control tuberculosis in nonhuman primates.
    Proc Natl Acad Sci U S A. 2019 Mar 8. pii: 1811380116.
    PubMed     Abstract available
    
    
    February 2019
32. NEIDEL S, Ren H, Torres AA, Smith GL, et al
    NF-kappaB activation is a turn on for vaccinia virus phosphoprotein A49 to turn off NF-kappaB activation.
    Proc Natl Acad Sci U S A. 2019 Feb 28. pii: 1813504116.
    PubMed     Abstract available
    
    
    
33. VANARSDALL AL, Chin AL, Liu J, Jardetzky TS, et al
    HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission.
    Proc Natl Acad Sci U S A. 2019;116:3728-3733.
    PubMed     Abstract available
    
    
    
34. TSENG YC, Wu CY, Liu ML, Chen TH, et al
    Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections.
    Proc Natl Acad Sci U S A. 2019 Feb 19. pii: 1819197116.
    PubMed     Abstract available
    
    
    January 2019
35. MARTINS MA, Bischof GF, Shin YC, Lauer WA, et al
    Vaccine protection against SIVmac239 acquisition.
    Proc Natl Acad Sci U S A. 2019 Jan 14. pii: 1814584116.
    PubMed     Abstract available
    
    
    December 2018
36. RAPPUOLI R, De Gregorio E, Costantino P
    On the mechanisms of conjugate vaccines.
    Proc Natl Acad Sci U S A. 2018 Dec 21. pii: 1819612116.
    PubMed    
    
    
    
37. BLOOM DE, Black S, Salisbury D, Rappuoli R, et al
    Antimicrobial resistance and the role of vaccines.
    Proc Natl Acad Sci U S A. 2018;115:12868-12871.
    PubMed    
    
    
    
38. SEVILLA JP, Bloom DE, Cadarette D, Jit M, et al
    Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR.
    Proc Natl Acad Sci U S A. 2018;115:12911-12919.
    PubMed     Abstract available
    
    
    
39. KENNEDY DA, Read AF
    Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance.
    Proc Natl Acad Sci U S A. 2018;115:12878-12886.
    PubMed     Abstract available
    
    
    
40. KLUGMAN KP, Black S
    Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effects.
    Proc Natl Acad Sci U S A. 2018;115:12896-12901.
    PubMed     Abstract available
    
    
    
41. TEDIJANTO C, Olesen SW, Grad YH, Lipsitch M, et al
    Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora.
    Proc Natl Acad Sci U S A. 2018;115:E11988-E11995.
    PubMed     Abstract available
    
    
    
42. BAKER SJ, Payne DJ, Rappuoli R, De Gregorio E, et al
    Technologies to address antimicrobial resistance.
    Proc Natl Acad Sci U S A. 2018;115:12887-12895.
    PubMed     Abstract available
    
    
    
43. KAPLONEK P, Khan N, Reppe K, Schumann B, et al
    Improving vaccines against Streptococcus pneumoniae using synthetic glycans.
    Proc Natl Acad Sci U S A. 2018 Dec 7. pii: 1811862115.
    PubMed     Abstract available
    
    
    
44. SUN X, Stefanetti G, Berti F, Kasper DL, et al
    Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines.
    Proc Natl Acad Sci U S A. 2018 Dec 3. pii: 1816401115.
    PubMed     Abstract available
    
    
    November 2018
45. POGORELYY MV, Minervina AA, Touzel MP, Sycheva AL, et al
    Precise tracking of vaccine-responding T cell clones reveals convergent and personalized response in identical twins.
    Proc Natl Acad Sci U S A. 2018 Nov 20. pii: 1809642115.
    PubMed     Abstract available
    
    
    
46. FINK AL, Engle K, Ursin RL, Tang WY, et al
    Biological sex affects vaccine efficacy and protection against influenza in mice.
    Proc Natl Acad Sci U S A. 2018 Nov 19. pii: 1805268115.
    PubMed     Abstract available
    
    
    
47. STEWART-JONES GBE, Chuang GY, Xu K, Zhou T, et al
    Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4.
    Proc Natl Acad Sci U S A. 2018 Nov 12. pii: 1811980115.
    PubMed     Abstract available
    
    
    September 2018
48. MICOLI F, Rondini S, Alfini R, Lanzilao L, et al
    Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella.
    Proc Natl Acad Sci U S A. 2018 Sep 27. pii: 1807655115.
    PubMed     Abstract available
    
    
    
49. CROFTS AA, Giovanetti SM, Rubin EJ, Poly FM, et al
    Enterotoxigenic E. coli virulence gene regulation in human infections.
    Proc Natl Acad Sci U S A. 2018;115:E8968-E8976.
    PubMed     Abstract available
    
    
    
50. BOTTERMANN M, Foss S, van Tienen LM, Vaysburd M, et al
    TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccination.
    Proc Natl Acad Sci U S A. 2018 Sep 12. pii: 1806314115.
    PubMed     Abstract available
    
    
    
51. HAABETH OAW, Blake TR, McKinlay CJ, Waymouth RM, et al
    mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice.
    Proc Natl Acad Sci U S A. 2018 Sep 10. pii: 1810002115.
    PubMed     Abstract available
    
    
    
52. PARKS RJ, Gussoni E
    Building immune tolerance through DNA vaccination.
    Proc Natl Acad Sci U S A. 2018 Sep 6. pii: 1813461115.
    PubMed    
    
    
    August 2018
53. JURASKA M, Magaret CA, Shao J, Carpp LN, et al
    Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials.
    Proc Natl Acad Sci U S A. 2018 Aug 20. pii: 1714250115.
    PubMed     Abstract available
    
    
    July 2018
54. DENG L, Chang TZ, Wang Y, Li S, et al
    Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice.
    Proc Natl Acad Sci U S A. 2018 Jul 31. pii: 1805713115.
    PubMed     Abstract available
    
    
    
55. LI W, Zhang X, Yang Y, Yin Q, et al
    Recognition of conserved antigens by Th17 cells provides broad protection against pulmonary Haemophilus influenzae infection.
    Proc Natl Acad Sci U S A. 2018;115:E7149-E7157.
    PubMed     Abstract available
    
    
    
56. 
    Retraction for Ganesh et al., Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.
    Proc Natl Acad Sci U S A. 2018 Jul 9. pii: 1806429115.
    PubMed    
    
    
    June 2018
57. ALEMAN F, Tzarum N, Kong L, Nagy K, et al
    Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors.
    Proc Natl Acad Sci U S A. 2018 Jun 28. pii: 1802378115.
    PubMed     Abstract available
    
    
    
58. SCHLEISS MR
    Recombinant cytomegalovirus glycoprotein B vaccine: Rethinking the immunological basis of protection.
    Proc Natl Acad Sci U S A. 2018 Jun 6. pii: 1806420115.
    PubMed    
    
    
    May 2018
59. BRYNILDSRUD OB, Eldholm V, Bohlin J, Uadiale K, et al
    Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa.
    Proc Natl Acad Sci U S A. 2018;115:5510-5515.
    PubMed     Abstract available
    
    
    
60. TZENG SY, McHugh KJ, Behrens AM, Rose S, et al
    Stabilized single-injection inactivated polio vaccine elicits a strong neutralizing immune response.
    Proc Natl Acad Sci U S A. 2018 May 21. pii: 1720970115.
    PubMed     Abstract available
    
    
    April 2018
61. SAH P, Medlock J, Fitzpatrick MC, Singer BH, et al
    Optimizing the impact of low-efficacy influenza vaccines.
    Proc Natl Acad Sci U S A. 2018 Apr 30. pii: 1802479115.
    PubMed     Abstract available
    
    
    
62. NELSON CS, Huffman T, Jenks JA, Cisneros de la Rosa E, et al
    HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions.
    Proc Natl Acad Sci U S A. 2018 Apr 30. pii: 1800177115.
    PubMed     Abstract available
    
    
    
63. BARANIAK I, Kropff B, Ambrose L, McIntosh M, et al
    Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies.
    Proc Natl Acad Sci U S A. 2018 Apr 23. pii: 1800224115.
    PubMed     Abstract available
    
    
    
64. PETTIGREW MM, Ahearn CP, Gent JF, Kong Y, et al
    Haemophilus influenzae genome evolution during persistence in the human airways in chronic obstructive pulmonary disease.
    Proc Natl Acad Sci U S A. 2018;115:E3256-E3265.
    PubMed     Abstract available
    
    
    
65. STEVENSON TC, Cywes-Bentley C, Moeller TD, Weyant KB, et al
    Immunization with outer membrane vesicles displaying conserved surface polysaccharide antigen elicits broadly antimicrobial antibodies.
    Proc Natl Acad Sci U S A. 2018;115:E3106-E3115.
    PubMed     Abstract available
    
    
    March 2018
66. OBOLSKI U, Lourenco J, Thompson C, Thompson R, et al
    Vaccination can drive an increase in frequencies of antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae.
    Proc Natl Acad Sci U S A. 2018 Mar 6. pii: 1718712115.
    PubMed     Abstract available
    
    
    January 2018
67. VERMA AA, Jimenez MP, Tangermann RH, Subramanian SV, et al
    Insecurity, polio vaccination rates, and polio incidence in northwest Pakistan.
    Proc Natl Acad Sci U S A. 2018 Jan 29. pii: 1711923115.
    PubMed     Abstract available
    
    
    December 2017
68. RAYMOND DD, Bajic G, Ferdman J, Suphaphiphat P, et al
    Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody.
    Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1715471115.
    PubMed     Abstract available
    
    
    
69. MANKOWSKI MC, Kinchen VJ, Wasilewski LN, Flyak AI, et al
    Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.
    Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1718441115.
    PubMed     Abstract available
    
    
    
70. PANANOS AD, Bury TM, Wang C, Schonfeld J, et al
    Critical dynamics in population vaccinating behavior.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1704093114.
    PubMed     Abstract available
    
    
    
71. WEISBERG AS, Maruri-Avidal L, Bisht H, Hansen BT, et al
    Enigmatic origin of the poxvirus membrane from the endoplasmic reticulum shown by 3D imaging of vaccinia virus assembly mutants.
    Proc Natl Acad Sci U S A. 2017 Dec 4. pii: 1716255114.
    PubMed     Abstract available
    
    
    November 2017
72. ZOST SJ, Parkhouse K, Gumina ME, Kim K, et al
    Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Proc Natl Acad Sci U S A. 2017 Nov 6. pii: 201712377.
    PubMed     Abstract available
    
    
    October 2017
73. KOEHLER H, Cotsmire S, Langland J, Kibler KV, et al
    Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3.
    Proc Natl Acad Sci U S A. 2017;114:11506-11511.
    PubMed     Abstract available
    
    
    
74. BUSTAMANTE LY, Powell GT, Lin YC, Macklin MD, et al
    Synergistic malaria vaccine combinations identified by systematic antigen screening.
    Proc Natl Acad Sci U S A. 2017 Oct 23. pii: 201702944.
    PubMed     Abstract available
    
    
    
75. LISBOA MP, Khan N, Martin C, Xu FF, et al
    Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5.
    Proc Natl Acad Sci U S A. 2017 Oct 2. pii: 201706875.
    PubMed     Abstract available
    
    
    May 2017
76. PIZZOLLA A, Wang Z, Groom JR, Kedzierska K, et al
    Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells.
    Proc Natl Acad Sci U S A. 2017 May 1. pii: 201620194.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: